Riskpilot← Back to searchSign inGet full accessLitomedu AB
ABDissolvedOrg 5592403462FalunGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK -1
EBITDA margin
637900.0%
-23% vs 2023
Equity ratio
27.7%
Financial strength
Net profit 2024
SEK -6K
-23% vs 2023
| Revenue | SEK -1 | — |
| EBITDA | SEK -6K | -23% |
| Net profit | SEK -6K | -23% |
| Total assets | SEK 28K | -19% |
| Equity | SEK 8K | -45% |
| Employees | 0 | — |
Legal name
Litomedu AB
Org number
5592403462
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska bedriva läkarverksamhet samt medicinsk och managementkonsultation inom hälso- och sjukvård, äga och förvalta fast egendom och värdepapper samt därmed förenlig verksamhet. Därtill ska bolaget bedriva management och konsultinsatser inom undervisning och utbildning.
Address
Falun
Email
forelaggande-bv2@standardbolag.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 | 0 | −0 | 0 | −0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −15 | −2 | −4 | −5 | −6 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −15 | −2 | −4 | −5 | −6 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −15 | −2 | −4 | −5 | −6 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −15 | −2 | −4 | −5 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 28 | 39 | 34 | 28 |
| Equity | 10 | 8 | 19 | 14 | 8 |
| Long-term debt | 20 | 20 | 20 | 20 | 20 |
| Short-term debt | 0 | 0 | — | — | — |
| Total debt | 20 | 20 | 20 | 20 | 20 |
EBITDA margin
-637900.0%
This company
15.8%
Market median
-4037442% vs market
20202024
Equity ratio
27.7%
This company
38.2%
Market median
-27% vs market
20202024
Return on equity
-82.2%
This company
18.4%
Market median
-547% vs market
20202024
Net profit margin
-629700.0%
This company
8.1%
Market median
-7774174% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.61×
This company
0.62×
Market median
-321% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AT Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
EF Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Litomedu AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Thomas Wohlin | Chief Executive Officer | 0 companies |
| Elisabeth Frieda Wohlin | Deputy Chief Executive Officer | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Anna Elisabet Viktoria Björk | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Board of Directors | 0 companies |